Adult-onset Still's disease following mRNA-1273 Moderna COVID-19 vaccination: A case report

IF 1.1 Q4 ALLERGY

Journal of Cutaneous Immunology and Allergy Pub Date : 2022-10-19 DOI:10.1002/cia2.12281

Masahiro Iwata MD, Tatsuya Ogawa MD, PhD, Keisuke Anju MD, Naoko Okiyama MD, PhD, Toshifumi Nomura MD, PhD

引用次数: 2

Abstract

A 57-year-old woman who was inoculated with the second dose of the mRNA-1273 Moderna COVID-19 vaccine and then developed adult-onset still’s disease as a result.

Abstract Image

查看原文本刊更多论文

mRNA - 1273现代COVID - 19疫苗接种后成人发病Still's病:1例报告

一名57岁的女性接种了第二剂信使核糖核酸1273莫德纳新冠肺炎疫苗，随后患上了成人发病的斯蒂尔病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cutaneous Immunology and Allergy Medicine-Dermatology

CiteScore

0.60

自引率

10.00%

发文量

审稿时长

12 weeks